XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2018   16,504,000        
Beginning balance at Dec. 31, 2018 $ 160,762 $ 17 $ 256,458 $ (153,900)   $ 58,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 21,998   21,998      
Issuance of common stock upon exercise of stock option grants (in shares)   34,000        
Issuance of common stock upon exercise of stock option grants 260   260      
Payment of employee withholding tax upon vesting of stock-based awards (198)   (198)      
Common stock repurchases (17,961)     (17,961)    
Other comprehensive loss 0          
Net (loss) income 14,313         14,313
Ending balance (in shares) at Dec. 31, 2019   16,538,000        
Ending balance at Dec. 31, 2019 179,174 $ 17 278,518 (171,861)   72,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense $ 24,756   24,756      
Issuance of common stock upon exercise of stock option grants (in shares) 149,473 149,000        
Issuance of common stock upon exercise of stock option grants $ 3,654   3,654      
Payment of employee withholding tax upon vesting of stock-based awards (1,525)   (1,525)      
Issuance of common stock related to vesting of restricted stock (in shares)   52,000        
Common stock repurchases (32,037)     (32,037)    
Other comprehensive loss 0          
Net (loss) income 11,989         11,989
Ending balance (in shares) at Dec. 31, 2020   16,739,000        
Ending balance at Dec. 31, 2020 186,011 $ 17 305,403 (203,898) $ 0 84,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense $ 19,555   19,555      
Issuance of common stock upon exercise of stock option grants (in shares) 122,847 101,000        
Issuance of common stock upon exercise of stock option grants $ 2,398   2,398      
Issuance of common stock related to vesting of restricted stock (in shares)   63,000        
Issuance of common stock related to vesting of restricted stock (1,577)   (1,577)      
Common stock repurchases (21,213)     (21,213)    
Other comprehensive loss (94)       (94)  
Net (loss) income (8,627)         (8,627)
Ending balance (in shares) at Dec. 31, 2021   16,903,000        
Ending balance at Dec. 31, 2021 $ 176,453 $ 17 $ 325,779 $ (225,111) $ (94) $ 75,862